Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06733038
Title FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients. (AtezoTRIBE2)
Acronym AtezoTRIBE2
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Gruppo Oncologico del Nord-Ovest
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
Istituto Oncologico Veneto Irccs RECRUITING Padova PD 35128 Italy Details
Nuovo Ospedale di Prato S. Stefano RECRUITING Prato PO 59100 Italy Details
U.O. Oncologia Medica 2 Universitaria - Azienda Ospedaliero-Universitaria Pisana Dipartimento di Ricerca Traslazionale e Nuove Tecnologie - University of Pisa RECRUITING Pisa 56126 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field